Melanocortin type 4 receptor agonist piperidinoylpyrrolidines
US8138188B2 · kind B2 · utility
0Cited by
15References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 19, 2007 |
| Grant date | Mar 20, 2012 |
| Priority date | — |
| Expiry date | Jul 18, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a class of melanocortin MCR4 agonists of general formula (I)wherein the variables and substituents are as defined herein and especially to selective MCR4 agonist compounds, to their use in medicine, particularly in the treatment of sexual dysfunction and obesity, to intermediates useful in their synthesis and to compositions containing them.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.